クオリプスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/05 | 3,400 | 3,800 | 3,355 | 3,740 | +390 | +11.6% | 378,200 |
| 2024/03/04 | 3,280 | 3,375 | 3,205 | 3,350 | +130 | +4% | 129,700 |
| 2024/03/01 | 3,180 | 3,265 | 3,060 | 3,220 | +20 | +0.6% | 157,200 |
| 2024/02/29 | 3,285 | 3,325 | 3,185 | 3,200 | -85 | -2.6% | 139,000 |
| 2024/02/28 | 3,395 | 3,465 | 3,230 | 3,285 | -115 | -3.4% | 207,000 |
| 2024/02/27 | 3,475 | 3,495 | 3,360 | 3,400 | -20 | -0.6% | 132,000 |
| 2024/02/26 | 3,300 | 3,500 | 3,205 | 3,420 | +175 | +5.4% | 201,500 |
| 2024/02/22 | 3,345 | 3,380 | 3,130 | 3,245 | -30 | -0.9% | 235,200 |
| 2024/02/21 | 3,245 | 3,360 | 3,220 | 3,275 | -40 | -1.2% | 171,600 |
| 2024/02/20 | 3,260 | 3,460 | 3,100 | 3,315 | -195 | -5.6% | 616,400 |
| 2024/02/19 | 3,705 | 3,780 | 3,490 | 3,510 | -210 | -5.6% | 451,900 |
| 2024/02/16 | 3,105 | 3,795 | 3,035 | 3,720 | +495 | +15.3% | 718,600 |
| 2024/02/15 | 3,200 | 3,285 | 2,985 | 3,225 | +170 | +5.6% | 688,800 |
| 2024/02/14 | 2,550 | 3,055 | 2,543 | 3,055 | +500 | +19.6% | 1,240,600 |
| 2024/02/13 | 2,515 | 2,581 | 2,472 | 2,555 | +115 | +4.7% | 332,000 |
| 2024/02/09 | 2,388 | 2,479 | 2,364 | 2,440 | +86 | +3.7% | 193,400 |
| 2024/02/08 | 2,340 | 2,400 | 2,296 | 2,354 | +40 | +1.7% | 132,500 |
| 2024/02/07 | 2,268 | 2,324 | 2,257 | 2,314 | +53 | +2.3% | 103,500 |
| 2024/02/06 | 2,300 | 2,330 | 2,251 | 2,261 | -25 | -1.1% | 105,100 |
| 2024/02/05 | 2,288 | 2,339 | 2,257 | 2,286 | -15 | -0.7% | 144,600 |
| 2024/02/02 | 2,395 | 2,442 | 2,291 | 2,301 | -82 | -3.4% | 222,000 |
| 2024/02/01 | 2,381 | 2,441 | 2,336 | 2,383 | -61 | -2.5% | 171,700 |
| 2024/01/31 | 2,441 | 2,530 | 2,425 | 2,444 | -36 | -1.5% | 144,200 |
| 2024/01/30 | 2,354 | 2,480 | 2,350 | 2,480 | +204 | +9% | 276,800 |
| 2024/01/29 | 2,500 | 2,506 | 2,227 | 2,276 | -212 | -8.5% | 413,400 |
| 2024/01/26 | 2,500 | 2,538 | 2,460 | 2,488 | -54 | -2.1% | 279,700 |
| 2024/01/25 | 2,385 | 2,551 | 2,358 | 2,542 | +170 | +7.2% | 498,900 |
| 2024/01/24 | 2,230 | 2,390 | 2,192 | 2,372 | +139 | +6.2% | 324,500 |
| 2024/01/23 | 2,262 | 2,327 | 2,230 | 2,233 | -3 | -0.1% | 216,900 |
| 2024/01/22 | 2,228 | 2,270 | 2,194 | 2,236 | +44 | +2% | 152,000 |
| 2024/01/19 | 2,137 | 2,217 | 2,093 | 2,192 | +79 | +3.7% | 161,000 |
| 2024/01/18 | 2,000 | 2,135 | 1,998 | 2,113 | +94 | +4.7% | 129,400 |
| 2024/01/17 | 2,063 | 2,081 | 2,010 | 2,019 | -56 | -2.7% | 129,800 |
| 2024/01/16 | 2,070 | 2,140 | 2,070 | 2,075 | +15 | +0.7% | 88,600 |
| 2024/01/15 | 2,060 | 2,082 | 2,014 | 2,060 | -40 | -1.9% | 105,300 |
| 2024/01/12 | 2,080 | 2,106 | 2,041 | 2,100 | +12 | +0.6% | 97,500 |
| 2024/01/11 | 2,160 | 2,162 | 2,075 | 2,088 | -70 | -3.2% | 143,800 |
| 2024/01/10 | 2,154 | 2,194 | 2,100 | 2,158 | -19 | -0.9% | 129,400 |
| 2024/01/09 | 2,074 | 2,189 | 2,050 | 2,177 | +153 | +7.6% | 188,200 |
| 2024/01/05 | 2,145 | 2,145 | 1,952 | 2,024 | -150 | -6.9% | 419,100 |
| 2024/01/04 | 2,283 | 2,299 | 2,174 | 2,174 | -147 | -6.3% | 293,000 |
| 2023/12/29 | 2,259 | 2,338 | 2,220 | 2,321 | +55 | +2.4% | 295,800 |
| 2023/12/28 | 2,089 | 2,268 | 2,078 | 2,266 | +198 | +9.6% | 361,900 |
| 2023/12/27 | 2,061 | 2,082 | 2,037 | 2,068 | +37 | +1.8% | 81,300 |
| 2023/12/26 | 2,080 | 2,118 | 2,031 | 2,031 | -11 | -0.5% | 139,500 |
| 2023/12/25 | 2,012 | 2,090 | 2,006 | 2,042 | +30 | +1.5% | 129,700 |
| 2023/12/22 | 1,995 | 2,030 | 1,976 | 2,012 | +12 | +0.6% | 95,000 |
| 2023/12/21 | 1,971 | 2,011 | 1,940 | 2,000 | +23 | +1.2% | 92,600 |
| 2023/12/20 | 1,995 | 2,031 | 1,977 | 1,977 | +1 | +0.1% | 116,100 |
| 2023/12/19 | 1,940 | 1,990 | 1,885 | 1,976 | +32 | +1.6% | 79,100 |
51～
100
件表示中 / 219件
類似銘柄と比較する
現在ご覧いただいている「クオリプス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| クオリプス | 323,000円 | -13.0% | - | 0.00% | - | 4.30倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| ステムリム | 46,500円 | -14.9% | -31.0% | 0.00% | 190.57倍 | 3.34倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| セルソース | 141,900円 | +19.0% | -13.1% | 0.35% | 39.09倍 | 4.57倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| 扶桑薬 | 228,700円 | +2.9% | +23.1% | 3.50% | 11.50倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| 大幸薬品 | 40,000円 | +11.1% | - | 0.00% | 36.50倍 | 2.98倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
